Head-To-Head Contrast: AIM ImmunoTech (NYSE:AIM) versus INmune Bio (NASDAQ:INMB)
INmune Bio (NASDAQ:INMB – Get Free Report) and AIM ImmunoTech (NYSE:AIM – Get Free Report) are both small-cap medical companies, but which is the superior...
Perion Network Ltd. (NASDAQ:PERI) Receives $12.13 Consensus Price Target from Brokerages
Perion Network Ltd. (NASDAQ:PERI – Get Free Report) has received an average rating of “Hold” from the six analysts that are presently covering the company,...
Monolithic Power Systems, Inc. (NASDAQ:MPWR) Receives $828.67 Average Price Target from Analysts
Shares of Monolithic Power Systems, Inc. (NASDAQ:MPWR – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the twelve ratings firms that...
Germany private sales Full Year 2024: VW T-Roc and Dacia Sandero in charge
This content is for members only. Visit the site and log in/register to read.
Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report released on Friday. The firm issued a sell rating...
StockNews.com Downgrades Meritage Homes (NYSE:MTH) to Sell
Meritage Homes (NYSE:MTH – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a research...